Nectin-2/CD112, Human
| $300.00 | |
| Z05671-100 | |
|
|
|
|
|
|
|
|
|
| Ask us a question | |
IVD Raw Materials
| $300.00 | |
| Z05671-100 | |
|
|
|
|
|
|
|
|
|
| Ask us a question | |
| Species | Human | |
| Protein Construction |
|
|
| Purity | > 95% as determined by BisTris PAGE | |
| Endotoxin Level | Less than 1EU per μg by the LAL method. | |
| Biological Activity | Measured by its binding ability in a functional ELISA. Test result was comparable to standard batch. | |
| Expression System | HEK293 | |
| Theoretical Molecular Weight | 35.54 kDa | |
| Apparent Molecular Weight | Due to glycosylation, the protein migrates to 45-55 kDa based on Bis-Tris PAGE result. | |
| Formulation | Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4). | |
| Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. | |
| Storage & Stability | Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles. |
Immobilized Nectin-2/CD112, Human, No Tag at 5 μg/ml (100 μl/well) on the plate. Dose response curve for Human PVRIG, mFc Tag with the EC50 of 76.1ng/ml determined by ELISA. »
The purity of Nectin-2/CD112, Human is greater than 95% as determined by SEC-HPLC. »
Nectin-2/CD112, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. »
| Target Background | Nectin-2 is an adhesion molecule that has been reported to play a role in tumor growth, metastasis and tumor angiogenesis. Nectin-2 expression in ovarian cancer may support tumor cell adhesion, leading to growth and lymph node metastasis. Effect of VEGF on Nectin-2 expression as well as permeability was investigated in HUVEC. |
| Synonyms | CD112; MPH; Nectin2; PRR2; PVRL2; HVEB; PVRR2 |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.